Nyxoah (Nyxoah) Scaled Net Operating Assets : 0.45 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Nyxoah Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Nyxoah's operating assets for the quarter that ended in Mar. 2024 was $74.69 Mil. Nyxoah's operating liabilities for the quarter that ended in Mar. 2024 was $14.21 Mil. Nyxoah's Total Assets for the quarter that ended in Dec. 2023 was $135.40 Mil. Therefore, Nyxoah's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.45.

Nyxoah Scaled Net Operating Assets Historical Data

The historical data trend for Nyxoah's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyxoah Scaled Net Operating Assets Chart

Nyxoah Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.28

1.18

0.20

0.21

0.37

Nyxoah Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.29	0.29	0.34	0.40	0.45

Competitive Comparison of Nyxoah's Scaled Net Operating Assets

For the Medical Instruments & Supplies subindustry, Nyxoah's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nyxoah's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Nyxoah's Scaled Net Operating Assets falls into.

Nyxoah Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Nyxoah's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(72.42	-	14.647)	/	154.736
=	0.37

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	135.395	-	62.975
=	72.42

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	28.501	-	12.529	-	1.325
=	14.647

Nyxoah's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(74.689	-	14.209)	/	135.395
=	0.45

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	122.843	-	48.154
=	74.689

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	28.064	-	12.553	-	1.302
=	14.209

Nyxoah Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Nyxoah's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nyxoah (Nyxoah) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (NAS:NYXH) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

5YI:Germany NYXH:Belgium

Address

Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435

Website

https://www.nyxoah.com

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.